Literature DB >> 2006632

Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia.

J Morganroth1, F V Brozovich, J T McDonald, R A Jacobs.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2006632     DOI： 10.1016/0002-9149(91)90541-r

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  34 in total

Review 1.  Assessing the cardiac safety of ebastine. Epilogue.

Authors:  D J Roberts
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

2.  Seasonal variability of QT dispersion in healthy young males.

Authors:  Sedat Kose; Kudret Aytemir; Ilknur Can; Atilla Iyisoy; Hurkan Kursaklioglu; Basri Amasyali; Ayhan Kilic; Ersoy Isik; Ali Oto; Ertan Demirtas
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-01       Impact factor: 1.468

Review 3.  The significance of QT interval in drug development.

Authors:  Rashmi R Shah
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 4.  Cardiac effects of ebastine and other antihistamines in humans.

Authors:  A J Moss; J Morganroth
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

5.  The QTc interval and its dispersion in patients receiving two atypical antipsychotics.

Authors:  Christoph U Correll; Anne M Frederickson; Vicki Figen; Elizabeth J Ginn-Scott; Rudy A Pantaleon Moya; John M Kane; Peter Manu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

Review 6.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

Review 7.  Safety biomarkers and the clinical development of oncology therapeutics: considerations for cardiovascular safety and risk management.

Authors:  Howard Fingert; Mary Varterasian
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

Review 8.  Opioids and Cardiac Arrhythmia: A Literature Review.

Authors:  Mina Behzadi; Siyavash Joukar; Ahmad Beik
Journal:  Med Princ Pract       Date:  2018-08-02       Impact factor: 1.927

9.  Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials.

Authors:  Mitesh J Borad; Arundhati D Soman; Martin Benjamin; Daniel Casa; Waibhav D Tembe; Barbara F Piper; Ramesh Ramanathan; Raoul Tibes; Gayle Jameson; Karen Ansaldo; Daniel D Von Hoff
Journal:  Invest New Drugs       Date:  2012-12-16       Impact factor: 3.850

10.  [A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy].

Authors:  R W Freudenmann
Journal:  Nervenarzt       Date:  2003-06-14       Impact factor: 1.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.